vs

Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and Sound Financial Bancorp, Inc. (SFBC). Click either name above to swap in a different company.

Sound Financial Bancorp, Inc. is the larger business by last-quarter revenue ($9.5M vs $7.8M, roughly 1.2× CRYO CELL INTERNATIONAL INC). On growth, Sound Financial Bancorp, Inc. posted the faster year-over-year revenue change (1.5% vs -2.3%). Sound Financial Bancorp, Inc. produced more free cash flow last quarter ($7.0M vs $1.2M). Over the past eight quarters, Sound Financial Bancorp, Inc.'s revenue compounded faster (5.5% CAGR vs -0.1%).

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

U.S. Bancorp is an American multinational banking institution headquartered in Minneapolis, Minnesota and incorporated in Delaware. It is the 5th-largest bank in the United States as of 2025. As the largest bank in the Midwestern United States, it is considered systemically important by the Financial Stability Board. It is the parent company of its primary operating entity, U.S. Bank National Association, which does business as U.S. Bank. The company provides banking, investment, mortgage, tr...

CCEL vs SFBC — Head-to-Head

Bigger by revenue
SFBC
SFBC
1.2× larger
SFBC
$9.5M
$7.8M
CCEL
Growing faster (revenue YoY)
SFBC
SFBC
+3.8% gap
SFBC
1.5%
-2.3%
CCEL
More free cash flow
SFBC
SFBC
$5.8M more FCF
SFBC
$7.0M
$1.2M
CCEL
Faster 2-yr revenue CAGR
SFBC
SFBC
Annualised
SFBC
5.5%
-0.1%
CCEL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCEL
CCEL
SFBC
SFBC
Revenue
$7.8M
$9.5M
Net Profit
$-3.8M
Gross Margin
77.9%
Operating Margin
-50.6%
27.1%
Net Margin
-48.7%
Revenue YoY
-2.3%
1.5%
Net Profit YoY
-105.1%
EPS (diluted)
$-0.46
$0.87

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCEL
CCEL
SFBC
SFBC
Q4 25
$7.8M
$9.5M
Q3 25
$7.8M
$9.8M
Q2 25
$7.9M
$10.4M
Q1 25
$8.0M
$9.2M
Q4 24
$8.0M
$9.4M
Q3 24
$8.1M
$9.1M
Q2 24
$8.0M
$8.6M
Q1 24
$7.9M
$8.6M
Net Profit
CCEL
CCEL
SFBC
SFBC
Q4 25
$-3.8M
Q3 25
$749.4K
$1.7M
Q2 25
$355.8K
$2.1M
Q1 25
$282.9K
$1.2M
Q4 24
$-1.9M
Q3 24
$1.1M
$1.2M
Q2 24
$655.8K
$795.0K
Q1 24
$556.2K
$770.0K
Gross Margin
CCEL
CCEL
SFBC
SFBC
Q4 25
77.9%
Q3 25
77.0%
Q2 25
76.6%
Q1 25
75.1%
Q4 24
78.4%
Q3 24
73.6%
Q2 24
74.8%
Q1 24
73.7%
Operating Margin
CCEL
CCEL
SFBC
SFBC
Q4 25
-50.6%
27.1%
Q3 25
24.3%
21.3%
Q2 25
18.8%
24.5%
Q1 25
13.3%
15.9%
Q4 24
-1.5%
24.6%
Q3 24
17.2%
15.6%
Q2 24
17.3%
11.4%
Q1 24
10.5%
10.9%
Net Margin
CCEL
CCEL
SFBC
SFBC
Q4 25
-48.7%
Q3 25
9.6%
17.3%
Q2 25
4.5%
19.8%
Q1 25
3.5%
12.7%
Q4 24
-23.2%
Q3 24
13.0%
12.7%
Q2 24
8.2%
9.2%
Q1 24
7.1%
9.0%
EPS (diluted)
CCEL
CCEL
SFBC
SFBC
Q4 25
$-0.46
$0.87
Q3 25
$0.09
$0.66
Q2 25
$0.04
$0.79
Q1 25
$0.03
$0.45
Q4 24
$-0.23
$0.74
Q3 24
$0.13
$0.45
Q2 24
$0.08
$0.31
Q1 24
$0.07
$0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCEL
CCEL
SFBC
SFBC
Cash + ST InvestmentsLiquidity on hand
$3.3M
$138.5M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$-18.6M
$109.4M
Total Assets
$61.7M
$1.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCEL
CCEL
SFBC
SFBC
Q4 25
$3.3M
$138.5M
Q3 25
$3.2M
$101.2M
Q2 25
$4.4M
$102.5M
Q1 25
$3.5M
$131.5M
Q4 24
$3.5M
$43.6M
Q3 24
$2.1M
$148.9M
Q2 24
$1.5M
$135.1M
Q1 24
$979.6K
$138.0M
Total Debt
CCEL
CCEL
SFBC
SFBC
Q4 25
$8.4M
Q3 25
$8.4M
Q2 25
$8.4M
Q1 25
$8.5M
Q4 24
$8.5M
Q3 24
$8.5M
Q2 24
$8.5M
Q1 24
$8.6M
Stockholders' Equity
CCEL
CCEL
SFBC
SFBC
Q4 25
$-18.6M
$109.4M
Q3 25
$-14.8M
$107.5M
Q2 25
$-15.6M
$106.0M
Q1 25
$-14.7M
$104.4M
Q4 24
$-13.2M
$103.7M
Q3 24
$-9.6M
$102.2M
Q2 24
$-10.7M
$101.3M
Q1 24
$-10.3M
$101.0M
Total Assets
CCEL
CCEL
SFBC
SFBC
Q4 25
$61.7M
$1.1B
Q3 25
$63.2M
$1.1B
Q2 25
$64.4M
$1.1B
Q1 25
$64.4M
$1.1B
Q4 24
$64.7M
$993.6M
Q3 24
$62.9M
$1.1B
Q2 24
$62.6M
$1.1B
Q1 24
$61.7M
$1.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCEL
CCEL
SFBC
SFBC
Operating Cash FlowLast quarter
$1.3M
$7.2M
Free Cash FlowOCF − Capex
$1.2M
$7.0M
FCF MarginFCF / Revenue
15.5%
73.4%
Capex IntensityCapex / Revenue
0.9%
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.2M
$12.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCEL
CCEL
SFBC
SFBC
Q4 25
$1.3M
$7.2M
Q3 25
$2.5M
$3.8M
Q2 25
$707.0K
$-494.0K
Q1 25
$954.1K
$1.9M
Q4 24
$2.2M
$2.9M
Q3 24
$2.4M
$3.3M
Q2 24
$1.8M
$-4.0M
Q1 24
$-356.9K
$3.5M
Free Cash Flow
CCEL
CCEL
SFBC
SFBC
Q4 25
$1.2M
$7.0M
Q3 25
$2.5M
$3.8M
Q2 25
$644.6K
$-518.0K
Q1 25
$892.0K
$1.8M
Q4 24
$2.1M
$2.9M
Q3 24
$2.3M
$3.2M
Q2 24
$21.5K
$-5.6M
Q1 24
$-814.6K
$1.9M
FCF Margin
CCEL
CCEL
SFBC
SFBC
Q4 25
15.5%
73.4%
Q3 25
31.9%
38.3%
Q2 25
8.1%
-5.0%
Q1 25
11.2%
19.8%
Q4 24
26.8%
30.4%
Q3 24
27.9%
35.5%
Q2 24
0.3%
-65.4%
Q1 24
-10.4%
22.2%
Capex Intensity
CCEL
CCEL
SFBC
SFBC
Q4 25
0.9%
1.8%
Q3 25
0.5%
0.4%
Q2 25
0.8%
0.2%
Q1 25
0.8%
0.4%
Q4 24
0.1%
0.8%
Q3 24
2.3%
0.5%
Q2 24
21.8%
18.7%
Q1 24
5.8%
19.0%
Cash Conversion
CCEL
CCEL
SFBC
SFBC
Q4 25
Q3 25
3.38×
2.24×
Q2 25
1.99×
-0.24×
Q1 25
3.37×
1.59×
Q4 24
Q3 24
2.32×
2.84×
Q2 24
2.70×
-5.05×
Q1 24
-0.64×
4.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons